SV2A and schizophrenia: Recent studies found no effect of haloperidol or olanzapine administration on SV2A protein levels or specific binding in the rat brain, suggesting antipsychotic treatment is unlikely to affect the [11C]UCB-J measure in schizophrenia patients [30, 62].